SANOFI CONS HEALTHC IND L
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more
SANOFI CONS HEALTHC IND L (SANOFICONR) - Total Liabilities
Latest total liabilities as of December 2025: ₹1.63 Billion INR
Based on the latest financial reports, SANOFI CONS HEALTHC IND L (SANOFICONR) has total liabilities worth ₹1.63 Billion INR as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SANOFI CONS HEALTHC IND L - Total Liabilities Trend (2023–2025)
This chart illustrates how SANOFI CONS HEALTHC IND L's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SANOFI CONS HEALTHC IND L Competitors by Total Liabilities
The table below lists competitors of SANOFI CONS HEALTHC IND L ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LiaonWellhope Agri-Tech Co Ltd
SHG:603609
|
China | CN¥10.83 Billion |
|
BR Advisory Partners
SA:BRBI11
|
Brazil | R$16.70 Billion |
|
Clearfield Inc
NASDAQ:CLFD
|
USA | $18.40 Million |
|
CAC Nantong Chemical Co., Ltd.
SHE:301665
|
China | CN¥2.29 Billion |
|
Hubei Guochuang Hi-tech Material Co Ltd
SHE:002377
|
China | CN¥630.77 Million |
|
SNDL Inc.
NASDAQ:SNDL
|
USA | $218.77 Million |
|
SF Urban Properties AG
SW:SFPN
|
Switzerland | CHF508.15 Million |
|
Audinate Group Limited
PINK:AUDGF
|
USA | $17.09 Million |
Liability Composition Analysis (2023–2025)
This chart breaks down SANOFI CONS HEALTHC IND L's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SANOFI CONS HEALTHC IND L's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SANOFI CONS HEALTHC IND L (2023–2025)
The table below shows the annual total liabilities of SANOFI CONS HEALTHC IND L from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₹1.63 Billion | +2.97% |
| 2024-12-31 | ₹1.58 Billion | +14.88% |
| 2023-12-31 | ₹1.38 Billion | -- |